MOL-4239

• CAT Number: I032515
• CAS Number: 1204306-34-2
• Molecular Formula: C19H16BrN3O
• Molecular Weight: 382.26
• Purity: 98%
• Synonyms: MOL-4239; MOL 4239; MOL4239
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (2E,4E)-5-(6-bromopyridin-2-yl)-2-cyano-N-[(1S)-1-phenylethyl]penta-2,4-dienamide
• InChI: InChI=1S/C19H16BrN3O/c1-14(15-7-3-2-4-8-15)22-19(24)16(13-21)9-5-10-17-11-6-12-18(20)23-17/h2-12,14H,1H3,(H,22,24)/b10-5+,16-9+/t14-/m0/s1
• InChIKey: IVAUEQVCSQZMGV-QIUCFAMLSA-N
• SMILES: C[C@@H](C1=CC=CC=C1)NC(=O)/C(=C/C=C/C2=NC(=CC=C2)Br)/C#N

MOL-4239（Cat No.:I032515）is a small molecule inhibitor primarily studied for its potential in cancer therapy. It acts by targeting and inhibiting specific proteins involved in tumor growth, often in the context of solid tumors. The compound has demonstrated selectivity for its molecular targets, which are key in cell proliferation, survival, and metastasis. Preclinical studies suggest that MOL-4239 can enhance the effectiveness of other cancer therapies, offering a synergistic effect. Research is ongoing to evaluate its safety, efficacy, and potential role in clinical oncology treatments, especially in combination therapies.